Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052947072> ?p ?o ?g. }
- W2052947072 endingPage "1061" @default.
- W2052947072 startingPage "1051" @default.
- W2052947072 abstract "Summary The incidence of non‐steroidal anti‐inflammatory drug‐related ulcer complications remains high despite the availability of potent anti‐ulcer drugs and selective cyclo‐oxygenase‐2 inhibitors. Non‐steroidal anti‐inflammatory drug‐related ulcer complications can be minimized by prospective assessment of patients’ baseline risk, rational choice and use of non‐steroidal anti‐inflammatory drugs, and selective use of co‐therapy strategies with gastroprotectives. Current recommendations regarding strategies using anti‐ulcer drugs and cyclo‐oxygenase‐2 inhibitors for prevention of clinical non‐steroidal anti‐inflammatory drug upper gastrointestinal events are largely derived from studies using surrogates such as endoscopic ulcers, erosions, and symptoms in low‐ to average‐risk patients. Conclusions based on surrogate and potentially manipulatable end‐points are increasingly suspect with regard to applicability to clinical situations. This article reviews the risks associated with non‐steroidal anti‐inflammatory drugs including aspirin and includes the effect of the patients’ baseline risk, and the confounding effects of Helicobacter pylori infection. In addition, uncertainties regarding the clinical efficacy of anti‐ulcer drugs and cyclo‐oxygenase‐2 inhibitors against non‐steroidal anti‐inflammatory drug‐related ulcer complications are put into perspective. We propose management strategies based on the risk category: low risk (absence of risk factors) (least ulcerogenic non‐steroidal anti‐inflammatory drug at lowest effective dose), moderate risk (one to two risk factors) (as above, plus an antisecretory agent or misoprostol or a cyclo‐oxygenase‐2 inhibitor), high risk (multiple risk factors or patients using concomitant low‐dose aspirin, steroids, or anticoagulants) (cyclo‐oxygenase‐2 inhibitor alone with steroids, plus misoprostol with warfarin, or plus a proton pump inhibitors or misoprostol with aspirin), and very high risk (history of ulcer complications) (avoid all non‐steroidal anti‐inflammatory drugs, if possible or a cyclo‐oxygenase‐2 plus a proton pump inhibitors and/or misoprostol). The presence of H. pylori infection increases the risk of upper gastrointestinal complications in non‐steroidal anti‐inflammatory drug users by two‐ to fourfold suggesting that all patients requiring regular non‐steroidal anti‐inflammatory drug therapy be tested for H. pylori ." @default.
- W2052947072 created "2016-06-24" @default.
- W2052947072 creator A5053556585 @default.
- W2052947072 creator A5085313387 @default.
- W2052947072 date "2004-04-19" @default.
- W2052947072 modified "2023-10-17" @default.
- W2052947072 title "Prevention of non-steroidal anti-inflammatory drug gastrointestinal complications - review and recommendations based on risk assessment" @default.
- W2052947072 cites W1489584806 @default.
- W2052947072 cites W1967083260 @default.
- W2052947072 cites W1967276177 @default.
- W2052947072 cites W1977809739 @default.
- W2052947072 cites W1980155504 @default.
- W2052947072 cites W1987043570 @default.
- W2052947072 cites W1989726504 @default.
- W2052947072 cites W1992436643 @default.
- W2052947072 cites W1996405559 @default.
- W2052947072 cites W1998161037 @default.
- W2052947072 cites W2001350224 @default.
- W2052947072 cites W2008729062 @default.
- W2052947072 cites W2011327495 @default.
- W2052947072 cites W2017818343 @default.
- W2052947072 cites W2031760606 @default.
- W2052947072 cites W2034013987 @default.
- W2052947072 cites W2034468337 @default.
- W2052947072 cites W2037942670 @default.
- W2052947072 cites W2044292672 @default.
- W2052947072 cites W2050094063 @default.
- W2052947072 cites W2051691071 @default.
- W2052947072 cites W2053746829 @default.
- W2052947072 cites W2054154014 @default.
- W2052947072 cites W2054883739 @default.
- W2052947072 cites W2066905319 @default.
- W2052947072 cites W2071335057 @default.
- W2052947072 cites W2073714032 @default.
- W2052947072 cites W2076649591 @default.
- W2052947072 cites W2080195394 @default.
- W2052947072 cites W2082999830 @default.
- W2052947072 cites W2094502777 @default.
- W2052947072 cites W2098458064 @default.
- W2052947072 cites W2105811856 @default.
- W2052947072 cites W2110739516 @default.
- W2052947072 cites W2130316297 @default.
- W2052947072 cites W2137408480 @default.
- W2052947072 cites W2143548707 @default.
- W2052947072 cites W2157782064 @default.
- W2052947072 cites W2160359747 @default.
- W2052947072 cites W2163756514 @default.
- W2052947072 cites W2164290354 @default.
- W2052947072 cites W2313437711 @default.
- W2052947072 cites W2330496155 @default.
- W2052947072 cites W2333044470 @default.
- W2052947072 cites W2339197236 @default.
- W2052947072 cites W4235682442 @default.
- W2052947072 cites W2034986319 @default.
- W2052947072 doi "https://doi.org/10.1111/j.1365-2036.2004.01935.x" @default.
- W2052947072 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15142194" @default.
- W2052947072 hasPublicationYear "2004" @default.
- W2052947072 type Work @default.
- W2052947072 sameAs 2052947072 @default.
- W2052947072 citedByCount "128" @default.
- W2052947072 countsByYear W20529470722012 @default.
- W2052947072 countsByYear W20529470722013 @default.
- W2052947072 countsByYear W20529470722014 @default.
- W2052947072 countsByYear W20529470722015 @default.
- W2052947072 countsByYear W20529470722016 @default.
- W2052947072 countsByYear W20529470722017 @default.
- W2052947072 countsByYear W20529470722018 @default.
- W2052947072 countsByYear W20529470722019 @default.
- W2052947072 countsByYear W20529470722020 @default.
- W2052947072 countsByYear W20529470722021 @default.
- W2052947072 countsByYear W20529470722022 @default.
- W2052947072 countsByYear W20529470722023 @default.
- W2052947072 crossrefType "journal-article" @default.
- W2052947072 hasAuthorship W2052947072A5053556585 @default.
- W2052947072 hasAuthorship W2052947072A5085313387 @default.
- W2052947072 hasConcept C126322002 @default.
- W2052947072 hasConcept C2776409635 @default.
- W2052947072 hasConcept C2777628954 @default.
- W2052947072 hasConcept C2778642596 @default.
- W2052947072 hasConcept C2779199973 @default.
- W2052947072 hasConcept C2779234561 @default.
- W2052947072 hasConcept C2779703632 @default.
- W2052947072 hasConcept C2780035454 @default.
- W2052947072 hasConcept C50440223 @default.
- W2052947072 hasConcept C54355233 @default.
- W2052947072 hasConcept C71924100 @default.
- W2052947072 hasConcept C86803240 @default.
- W2052947072 hasConcept C98274493 @default.
- W2052947072 hasConceptScore W2052947072C126322002 @default.
- W2052947072 hasConceptScore W2052947072C2776409635 @default.
- W2052947072 hasConceptScore W2052947072C2777628954 @default.
- W2052947072 hasConceptScore W2052947072C2778642596 @default.
- W2052947072 hasConceptScore W2052947072C2779199973 @default.
- W2052947072 hasConceptScore W2052947072C2779234561 @default.
- W2052947072 hasConceptScore W2052947072C2779703632 @default.
- W2052947072 hasConceptScore W2052947072C2780035454 @default.
- W2052947072 hasConceptScore W2052947072C50440223 @default.
- W2052947072 hasConceptScore W2052947072C54355233 @default.